Same Carrier, Different Outcomes: Molecular Identity Shapes the Physicochemical and Biological Performance of Curcumin- and Resveratrol-Loaded PCL Nanoparticles
Pharmaceutics · 20.11.2026 · 18 (11) · 1499
DOI: 10.3390/pharmaceutics18111499 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 20.11.2026. Verfasst von Romero-Montero Alejandra und 8 weiteren Autor:innen. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: doctoral Scholarship Program.
Abstract (Originalsprache)
Background/Objectives: The molecular identity of encapsulated bioactive compounds may influence nanoparticle performance even when the same polymeric carrier is used. This study compared the physicochemical properties and biological responses of curcumin (CUR)- and resveratrol (RSV)-loaded poly(ε-caprolactone) (PCL) nanoparticles.
Methods
Nanoparticles were prepared via nanoprecipitation using different stabilizer systems and characterized in terms of particle size, polydispersity, zeta potential, encapsulation efficiency, drug loading, thermal behavior, and in vitro release. Antibacterial activity against Pseudomonas aeruginosa, fibroblast metabolic activity, and zebrafish embryo survival were also evaluated.
Results
Drug-loaded nanoparticles exhibited hydrodynamic diameters of approximately 219–285 nm. CUR formulations showed higher encapsulation efficiencies (92.78–96.46%) and drug loading (4.56–4.82%) than RSV formulations (74.52–78.83% and 3.73–3.94%, respectively). After 96 h, cumulative release reached approximately 86% for CUR and 65% for RSV. RSV-loaded nanoparticles exhibited greater antibacterial growth inhibition under the evaluated conditions. Free CUR and RSV showed concentration-dependent inhibition of fibroblast metabolic activity, whereas both nanoparticle formulations maintained relative metabolic activity above approximately 65% across the tested concentrations. In zebrafish embryos, survival remained at least 93.3% at 96 h post-fertilization, without statistically significant concentration-dependent effects in mixed-effects analyses.
Conclusions
Molecular identity influenced drug incorporation, release behavior, and biological responses within the same PCL carrier system. These findings underscore the importance of evaluating individual drug–carrier combinations and support further investigation of their therapeutic potential.
Förderung
- doctoral Scholarship Program
Zitieren
APA
Alejandra, R., Ximena, M., Karina, C. L., Guadalupe, T. D., Israel, N. T., Melissa, G., María, H. L. D. L. B., Samantha, C., & Luisa, D. P. M. (2026). Same Carrier, Different Outcomes: Molecular Identity Shapes the Physicochemical and Biological Performance of Curcumin- and Resveratrol-Loaded PCL Nanoparticles. Pharmaceutics, 18(11), 1499. https://doi.org/10.3390/pharmaceutics18111499
Vancouver
Alejandra R, Ximena M, Karina CL, Guadalupe TD, Israel NT, Melissa G, et al. Same Carrier, Different Outcomes: Molecular Identity Shapes the Physicochemical and Biological Performance of Curcumin- and Resveratrol-Loaded PCL Nanoparticles. Pharmaceutics. 2026;18(11):1499. doi:10.3390/pharmaceutics18111499
BibTeX
@article{Alejandra2026,
author = {Alejandra, Romero-Montero and Ximena, Matias-Mercado and Karina, Caspi-Chasi Liza and Guadalupe, Tlelo-Reyes Dimani and Israel, Núñez Tapia and Melissa, González-Miramón and María, Herrera León de la Barra and Samantha, Carrillo-Rosas and Luisa, Del Prado-Audelo María},
title = {Same Carrier, Different Outcomes: Molecular Identity Shapes the Physicochemical and Biological Performance of Curcumin- and Resveratrol-Loaded PCL Nanoparticles},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {11},
pages = {1499},
doi = {10.3390/pharmaceutics18111499}
}
EUVIMED